To access a recording of this webinar or receive a copy of the slides, please contact [email protected].

The Hatch-Waxman Act was enacted by Congress to encourage innovation in pharmaceutical research and development, and shorten the time to market for generic drugs. Fish’s award-winning life sciences practice has developed a four-part webinar series to examine and explain the Act in detail.

Chad Shear, an experienced life sciences trial lawyer, presented the first program in the series, Hatch-Waxman 101.

Introduce the Hatch-Waxman Act;
Explore the policy underpinning the Act;
Discuss the approval process and requirements; and
Examine how exclusivity works.

This complimentary webinar is perfect for those who have limited experience with the Hatch-Waxman Act. It will become the foundation for more advanced discussions in subsequent webinars in the series.

Hatch-Waxman 101

The FTC and the Orange Book: Considerations for Patent Owners

Analyzing SEPs: Strategies to Avoid or Prepare for Litigation

How a Second Trump Presidency Could Shape IP

Texas Patent Litigation Monthly Wrap-Up: October 2024

Women’s Health Tech Entrepreneurs Combat Period Poverty and Increase Representation at the USPTO

Trade Secrets: A Powerful Alternative to Noncompete Agreements

Should the Experimental Use Exception Be Broadened?

Duty of Disclosure and Consistency Requirements for Statements to PTO and Other Government Agencies

Taking a Good Deposition, Part II: Asking the Right Kind of Questions and Asking Them in the Right Way

The Final Word on an Alleged Infringer’s Intent in a Hatch-Waxman Safe Harbor Analysis

Preparing Your Company for Hatch-Waxman

Texas Patent Litigation Monthly Wrap-Up: July 2024